| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | — | -5.6% |
| Cost of Revenue | $1.6M | — | -1.8% |
| Gross Profit | $1.1M | — | -10.7% |
| R&D Expense | $1K | — | +0.0% |
| SG&A Expense | $2.0M | — | +2.8% |
| Operating Income | -$958K | — | -23.3% |
| Pre-tax Income | -$871K | — | -28.5% |
| Net Income | -$927K | — | -30.2% |
| EPS (Basic) | -$0.11 | — | -22.2% |
| EPS (Diluted) | -$0.11 | — | -22.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $662K | -1.6% | -28.5% |
| Inventory | $2.3M | +7.2% | +22.6% |
| Current Assets | $5.6M | +30.0% | +18.9% |
| Total Assets | $11.6M | +10.9% | +11.1% |
| Current Liabilities | $3.3M | +12.1% | +31.6% |
| Long-term Debt | $563K | -4.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$504K | — | -26.0% |
| Investing Cash Flow | -$9K | — | — |
| Financing Cash Flow | $1.6M | — | +833.5% |
| -15.0% |
| Total Liabilities | $7.1M | +27.8% | +46.1% |
| Stockholders' Equity | $4.0M | -10.4% | -23.3% |